Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David H. Ebb, M.D.

Co-Author

This page shows the publications co-authored by David Ebb and Karen Marcus.
Connection Strength

0.484
  1. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 05; 17(5):e174-5.
    View in: PubMed
    Score: 0.170
  2. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol. 2012 Jul 10; 30(20):2545-51.
    View in: PubMed
    Score: 0.130
  3. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-298.
    View in: PubMed
    Score: 0.042
  4. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8.
    View in: PubMed
    Score: 0.039
  5. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-1068.
    View in: PubMed
    Score: 0.037
  6. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9.
    View in: PubMed
    Score: 0.036
  7. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.